More and more school trips to the Balkans
Are the histories of the former Yugoslavia and Albania finally entering Europe’s space of memory? A constantly increasing number of Italian school trips to the region gives us reason to hope so.
Are the histories of the former Yugoslavia and Albania finally entering Europe’s space of memory? A constantly increasing number of Italian school trips to the region gives us reason to hope so.
The Coronavirus crisis is the first of its kind for the European Union. However, it is far from being the first existential crisis in the history of the Union.
EU heads of state and government failed to agree on a united response to the economic crisis triggered by COVID-19. Yet after the measures taken by the European Central Bank, there is no longer urgency to enact a measure like eurobonds.
We inaugurate a new format for EDJNet's newsletter: once a month, we send out a special newsletter with a thematic focus, while the standard newsletter comes out every two weeks. Here's the March focus.
EDJNet has done a data-driven analysis of rising temperatures in Italy between the 1960s and the 2010s, municipality by municipality. This note highlights the sources, the method and the techniques that were used
Centroids are sometimes quite far from the actual centre of a town or municipality. A presentation of another strategy to detect its coordinates, based on the European population grid.
Since the data available on the coronavirus pandemic is patchy and incomplete, it needs to be approached with caution and an awareness of what it can – and cannot – tell us about the deadly virus.
Calls have been coming from all sides for the EU to intervene in the COVID-19 crisis in the name of European solidarity. Although the Union has little room for manoeuvre in the public-health sphere, it can use the powerful lever of economic and monetary policy to counter the coming economic downturn.
Most of the drugs sold worldwide come from India and China, where production is cheapest. As a result, Europe’s supply of medicines is in the hands of a few companies.
The COVID-19 outbreak has revived fears over acute drug shortages in Europe, sparking calls to repatriate the production of pharmaceutical ingredients from China. But rebuilding capacity would take years, if it were even possible.